with heterozygous familial hypercholesterolemia, one with nonfamilial hypercholesterolemia, and seven normocholesterolemic subjects.' LDL was bound.by the membranes from normal subjects in a saturable manner that was inhibited by 56% in the presence ofexcess LDL. Binding of LDL was also inhibited by modification ofthe lipoproteins with 1,2-cyclohexanedione. The amount of 1251_ labeled LDL bound to membranes fromfamilial hypercholesterolemic livers that could be displaced with excess LDL was significantly less-than that bound by normocholesterolemic membranes. These observations suggest that LDL receptors are. expressed in normal human liver and are defective in the livers of familial hypercholesterolemic patients.
A substantial fraction of the low density lipoprotein (LDL) catabolized in the intact animal is degraded in the liver, but the extent to which this process is mediated by hepatic LDL receptors is controversial (1) . Membranes prepared from the livers of normal rabbits (2) or estrogen-treated rats (3) have been shown to possess saturable binding sites for LDL similar to the LDL receptors expressed in cultured skin fibroblasts from normal human subjects. Saturable LDL binding sites have also been detected in liver membranes from immature dogs and pigs (4) and from-human fetuses (5) . However, liver membranes from adult dogs and pigs do not express receptors for LDL, although LDL receptors can be induced in the livers ofadult dogs by prolongedfastingorbytreatingthe animals withcholestyramine (6) .
Treatment with cholestyramine has also been shown to stimulate LDL catabolism by the LDL receptor pathway in man (7) . This suggests that the human liver is capable ofexpressing LDL receptors, at least when the breakdown of hepatic cholesterol is stimulated. However, there remains the question as to how far hepatic LDL receptors contribute to the catabolism of LDL in man underphysiological conditions.
In this investigation, we have measured LDL binding activity in membranes from liver biopsies obtained from eight human subjects with normal or slightly raised cholesterol levels and from seven patients with heterozygous familial hypercholesterolemia (FH), a condition in which only halfthe normal number of LDL receptors is expressed in cultured fibroblasts (8) .
SUBJECTS AND METHODS
Samples of liver (0.5-L0 g).were obtained from 15 human subjects. Seven had normal plasma cholesterol concentrations (<6.5 mmol/liter or 250 mg/dl), and one had slight hypercholesterolemia not due to familial hypercholesterolemia (FH). None was known to be suffering from any metabolic disorder known to influence plasma lipoprotein metabolism. The other seven subjects had FH diagnosed on the basis of type-Ia or b hyperlipoproteinemia as well as an affected first-degree relative or tendon xanthomata (or both) and were undergoing partial ileal bypass as described (9) . Informed consent was obtained from all patients undergoing surgery. Wedge-biopsy of the liver is performed routinely by one of us (C. B.W.) during cholecystectomy and partial ileal bypass, primarily for histological purposes. All samples were obtained between 0800 and 1100 hr after the subject had fasted for at least 8 hr. All but one of the 15 subjects had received no drug known to affect cholesterol metabolism for at least 4 wk before the liver biopsies; one FH subject was receiving cholestyramine (16 g/day) . Relevant details of the subjects are shown in Table 1 .
Preparation of Liver Membranes. Membranes were prepared from the biopsy samples essentially as described by Kovanen et al (10) within l hr of surgery, during which time the liver sample was placed on ice in Dulbecco's phosphate-buffered saline (GIBCO). All subsequent procedures were carried out-at 40C.' The liver was minced, suspended in 30 ml of 0.01 M Tris.HCl/0.15 M NaCl/1 mM CaC12, pH 7.5, and homogenized with 20 strokes of a Teflon/glass homogenizer. After centrifugation for 10 min at 1,000 X gavg followed by centrifugation for 20 min at 8,000 X gag a membrane pellet was sedimented from the 8,000 x g supernatant by centrifugation for 60 min at 105,000 X gag in a Beckman 40 rotor. The pellet was suspended in 10 ml of 0.01 M Tris-HCl/0. 15 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisenmnt" in accordance with 18 U. S. C. §1734 solely to indicate this fact. Isolation and Labeling-of Lipoproteins. Plasma from normal human donors was obtained.from freshly drawn blood containing 0.01% EDTA. LDL (density, 1.019-1.055 g/ml) was isolated by differential centrifugation (11) and was labeled with Nal25I (Amersham International) by usiniodine monochloride (12) ; in some instances, 125I-labeled LDL 25I-LDL).was treated with 1,2-cyclohexanedione (Chd) as described (13) . Labeled and unlabeled lipoproteins were stored sterile in 0.15 M NaCl/1 mM EDTA, pH 7.4, at 40C for up to 2 wk with no apparent alteration in their properties. Chd-modified LDL was used within 24 hr of preparation. Before each experiment, 125I-LDL and LDL-ChD were dialyzed for 2 hr against 10 mM Tris HCl (pH 7.5) and the specific radioactivity was determined by using the method of Lowry et aL (14) to determine protein.concentration, with bovine serum albumin as standard. The sterile labeled lipoprotein solutions were diluted to a concentration of 0.15 mg of LDL protein/ml in 12.5 mM NaCl/0.5:mM'CaCJ2/50 mM Tris.HCl, pH 7.5, containing bovine serum albumin at 20-mg/ml (Sigma; fraction V, fatty acid free).
Experimental Procedure. On the day of the experiment, the membrane pellets were thawed and resuspended in 0.5 ml of 20 mM Tris.HCI/0.05 M NaCI/1 mM CaCl2, pH 7.5, by flushing through a 25-gauge needle. The suspension. was sonicated three times for 10 sec each at 0°C (sonicator peak-to-peak, 18 gm). The protein concentration, determined by the method of Lowry et al. (14) with bovine serum albumin as standard, was adjusted with resuspension buffer to 5 mg/ml. Unused sample was stored in liquid N2 in aliquots of approximately 250 p1 and used in subsequent assays after sonication for lOsec at 0°C. No sample was, frozen and thawed more than once after the initial sonication.
The binding assay was carried out essentially as described by Basu et al. (15) (1982) Proc. Natl Acad. Sci. USA 79 (1982) 6357 creased, suggesting that the LDL was binding to saturable sites on the membranes. When the assay was carried out with excess unlabeled LDL (1 mg of protein/ml) in the incubation mixture, much less '25I-LDL was bound at all concentrations, which confirmed that the binding of LDL was saturable. The addition of 30 mM EDTA also inhibited'binding of '"I-LDL to membranes but to a lesser extent than unlabeled LDL. In the presence of both EDTA and unlabeled LDL, the amount of "'I-LDL bound by the membranes was slightly lower than that bound in the presence of unlabeled LDL alone but it was not reduced to the level that would be expected if the effects of EDTA and unlabeled LDL were additive.
Liver membranes from the normocholesterolemic subject were also able to bind '"I-LDL-Chd, although less than one-third as much LDL-Chd was bound at any concentration tested. Neither the addition of EDTA (30 mM) nor the addition of unlabeled LDL (1 mg/ml) had any marked effect on the binding of LDL-Chd. A limited study of the effects of pH and ionic strength on LDL binding was made with the small amounts of biopsy material that were available. The results are shown in Table 2 . Saturable binding was higher at pH 7.5 than at pH 7.2 or pH 8.0 and was partially inhibited by increasing the NaCl concentration in the medium from 12.5 mM to 150 mM. EDTA-sensitive binding was higher at pH 8.0 than at pH 7.5 or pH 7.2 and was partially inhibited when the NaCl concentration was increased to 150 mM.
The ability of liver membranes from six heterozygous FH subjects and seven normocholesterolemic subjects to bind LDL to saturable or EDTA-sensitive binding sites was compared by using a concentration of 125I-LDL of 25 ,ug of protein/ml in the incubation mixture. The amount of LDL bound to saturable (Fig.   2) ; the difference between normocholesterolemic and FH subjects was statistically significant (P < 0.02). However, there was no difference in the amount of LDL bound to EDTA-sensitive binding sites at pH 7.5. Two subjects were excluded from the comparison in Fig. 2 : one subject with mild nonfamilial hypercholesterolemia (D.T.) and one FH subject who was taking 16 g of cholestyramine/day (W.P.). These subjects are included in the data shown in Fig. 3 , in which the saturable binding of LDL (6) were unable to demonstrate significant binding of LDL to membranes from the livers of three human adults, although these membranes expressed receptors for apoE-containing lipoproteins. having properties similar to the receptors on dog liver membranes, which recognize apoE but not apoB (apoE receptors) (4) . This discrepancy is difficult to explain, but it should be noted that, in our study, the membranes were prepared from fresh tissue within 1 hr of surgery whereas the membranes used by Mahley et al (6) were prepared from tissues frozen 72 hr previously. Also, the LDL receptors in dog liver are markedly influenced by nutritional and other factors (6) and it is possible that differences in the physiological states of the subjects at the time of operation contributed to the differences in the results of the two' studies.
We cannot'exclude the possibility that small amounts of apoEcontaining lipoproteins were present in our LDL preparations and that the. saturable binding observed was, in fact, due to binding by the apoE receptors present in human adult liver. However, this seems unlikely for several reasons. First, apoE was not detectable by NaDodSO4/polyacrylamide gel electrophoresis in the LDL preparation used in this study. Second, the binding of apoE-containing lipoproteins by the apoE receptor is independent of the salt concentration in the medium but is very sensitive to pH (4) whereas the saturable binding of LDL by human liver membranes was reduced by less than 25% when the pH was changed from 7.5 to 8.0. Finally, it is difficult to explain the difference between the binding' of LDL to normocholesterolemic and FH membranes in terms of the apoE receptor; Mahley et al. (6) found no evidence that the activity of the apoE receptor was subject to metabolic control by changes in cholesterol metabolism, and there is no evidence that FH homozygotes are unable to clear chylomicron remnants from the circulation to the extent that would be expected if their apoE receptors are defective.
In view of the strong inverse correlation between maximum saturable binding of LDL to hepatic membranes from an individual and his or her plasma cholesterol concentration, the possibility exists that the.reduced binding of LDL to FH membranes is a consequence of the high plasma cholesterol concentration rather than a reflection of a defect. in the LDL receptor in hepatic membranes. In.this context, it was of some interest that the two non-FH subjects who had the highest plasma cholesterol levels (C.G. and D.T.) also showed the lowest binding of LDL to saturable sites on the membranes, although there were not sufficient hypercholesterolemic non-FH subjects to determine the significance of this observation.
